| 10x Genomics Announces Patent Litigation Settlement Agreement with Bruker |
PLEASANTON, Calif. , May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. |
prnewswire.com |
2025-05-14 20:05:00 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade |
The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
zacks.com |
2025-05-13 15:00:58 |
Czytaj oryginał (ang.) |
| 10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript |
10x Genomics, Inc. (NASDAQ:TXG ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Cassie Corneau – Senior Director, Investor Relations Serge Saxonov – Chief Executive Officer and Co-Founder Adam Taich – Chief Financial Officer Conference Call Participants Patrick Donnelly – Citi Kyle Mikson – Canaccord Genuity Madeline Mollman – Wolfe Research Matt Sykes – Goldman Sachs Kyle Boucher – TD Cowen Operator Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded. |
seekingalpha.com |
2025-05-09 01:34:00 |
Czytaj oryginał (ang.) |
| Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics |
Although the revenue and EPS for 10x Genomics (TXG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-09 00:00:42 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates |
10x Genomics (TXG) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago. |
zacks.com |
2025-05-08 22:56:08 |
Czytaj oryginał (ang.) |
| 10x Genomics Reports First Quarter 2025 Financial Results |
PLEASANTON, Calif. , May 8, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2025. |
prnewswire.com |
2025-05-08 20:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Q1 2025 Results |
Results in line with expectations and tracking well to full-year guidance (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 7, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports the Company's financial and operational results for the three months ended March 31, 2025. Torex will host a conference call tomorrow morning at 9:00 AM (ET) to discuss the results. |
newsfilecorp.com |
2025-05-07 22:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Declares Commercial Production at Media Luna |
Milestone marks the Company's official transition to become both a gold and copper producer (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to announce it has achieved commercial production at the Media Luna mine, concluding the development phase of the Media Luna Project. Amongst other criteria, commercial production is declared when construction is substantially complete, mine and mill throughput have averaged over 40% and 60% of design rates for 30 days, respectively, product is saleable, and metallurgical recoveries have averaged at least 60% of the design recovery levels. |
newsfilecorp.com |
2025-05-01 22:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-05-01 15:08:22 |
Czytaj oryginał (ang.) |
| 10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference |
PLEASANTON, Calif. , April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference on Tuesday, May 13, at 11:20 a.m. |
prnewswire.com |
2025-04-30 20:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Q1 2025 Production Results |
Processing plant tie-ins concluded and first copper concentrate achieved; quarterly production in line with plan (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports Q1 2025 gold equivalent ("AuEq") payable production of 59,630 ounces ("oz") and AuEq sold of 60,568 oz. The Company is on track to achieve annual payable production guidance of 400,000 to 450,000 oz AuEq1. |
newsfilecorp.com |
2025-04-10 22:00:00 |
Czytaj oryginał (ang.) |
| Vizgen Announces End of Litigation with 10x Genomics and Harvard University |
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #neuroscience--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an open letter in response to the settlement of litigation between Vizgen, Harvard University and 10X Genomics in the United States District Court for the District of Delaware. Dear Customers, Researchers and Friends of Vizgen: On February 5th, we secured an important settlement putting an end to litigation, including. |
businesswire.com |
2025-04-03 12:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports First Copper Concentrate Production from Media Luna |
Processing plant tie-ins and restart complete; commercial production expected in coming weeks(All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces completion of the four-week tie-in period for the Media Luna Project ("Media Luna") and first production of precious metal-rich copper concentrate. Jody Kuzenko, President and CEO of Torex, stated: "Following almost three years to the day of the release of our feasibility study for the Media Luna Project, we have completed the tie-in period at our processing plant and achieved first production of copper concentrate. |
newsfilecorp.com |
2025-03-24 20:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics: Lower Cost Innovation May Drive A Rebound |
I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption, particularly in the biopharma sector, presenting significant revenue opportunities. Despite historical underperformance and high risk, TXG's leading technologies and potential market penetration justify holding the stock at current price levels. |
seekingalpha.com |
2025-03-20 05:12:55 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Year-End 2024 Reserves & Resources |
Drilling success continues to support reserve life extensions (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to report year-end 2024 mineral reserves and resources for the Morelos Complex, which includes the producing El Limón Guajes ("ELG") Mine Complex (consisting of the ELG Open Pits and ELG Underground), Media Luna Underground mine, development phase EPO Underground deposit, and surface stockpiles. Table 1: Year-over-year comparison of mineral reserves & mineral resources for the Morelos Complex December 31, 2024 December 31, 2023 Variance Tonnes AuEq AuEq Tonnes AuEq AuEq Tonnes AuEq AuEq (kt) (gpt) (koz) (kt) (gpt) (koz) (kt) (gpt) (koz) Proven & Probable Reserves Media Luna Underground 24,180 4.26 3,311 23,569 4.43 3,360 3% (4%) (1%) ELG Underground 4,019 5.12 662 3,504 5.81 654 15% (12%) 1% EPO Underground 5,029 4.83 781 - - - na na na ELG Open Pit 945 2.69 82 5,553 3.16 565 (83%) (15%) (86%) Surface Stockpiles 6,235 1.30 261 4,972 1.20 192 25% 8% 36% Total Morelos Complex 40,408 3.92 5,096 37,598 3.95 4,771 7% (1%) 7% Measured & Indicated Resources Media Luna Underground 29,114 5.07 4,744 27,451 5.23 4,618 6% (3%) 3% ELG Underground 8,451 5.20 1,414 8,176 5.48 1,441 3% (5%) (2%) EPO Underground 7,060 5.18 1,176 6,979 5.14 1,153 1% 1% 2% ELG Open Pit 1,054 2.86 97 6,110 3.13 615 (83%) (9%) (84%) Total Morelos Complex 45,679 5.06 7,431 48,717 5.00 7,828 (6%) 1% (5%) Inferred Resources Media Luna Underground 7,675 4.12 1,017 7,330 4.25 1,001 5% (3%) 2% ELG Underground 1,961 4.30 271 2,396 5.28 407 (18%) (19%) (33%) EPO Underground 6,883 4.31 954 4,960 4.52 721 39% (5%) 32% ELG Open Pit 6 3.65 1 399 2.08 27 (98%) 75% (97%) Total Morelos Complex 16,526 4.22 2,243 15,085 4.45 2,156 10% (5%) 4% Notes to Table: 1. |
newsfilecorp.com |
2025-03-19 20:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products |
10x Genomics' ATAC-Seq patents found valid and infringed PLEASANTON, Calif. , March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. |
prnewswire.com |
2025-03-03 18:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Excellent Drill Results from Media Luna West and Initial Results from Media Luna East |
Compelling results return multiple high-grade intercepts at both Media Luna East and West (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 24, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to provide results from the ongoing drilling program at Media Luna West and results from initial drill testing at Media Luna East. Drilling at both targets supports the Company's exploration strategy, which is focused, in part, on unlocking additional near-mine opportunities at the Media Luna Cluster in order to further enhance and extend the production profile of the Morelos Complex. |
newsfilecorp.com |
2025-02-24 08:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis |
New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms PLEASANTON, Calif. , Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product innovations to solidify its position as the best partner for high-performance single cell research at scale. |
prnewswire.com |
2025-02-23 13:30:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Q4 and Full Year 2024 Results |
2024 marks another solid year of operational and financial results; on track to return to positive free cash flow generation by mid-2025 (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 19, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports the Company's financial and operational results for the three months and year ended December 31, 2024. Torex will host a conference call tomorrow morning at 9:00 AM (ET) to discuss the results. |
newsfilecorp.com |
2025-02-19 20:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference |
PLEASANTON, Calif. , Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, at 11:10 a.m. |
prnewswire.com |
2025-02-18 18:05:00 |
Czytaj oryginał (ang.) |
| Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties |
On Wednesday, 10x Genomics Inc TXG reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of $(0.30). |
benzinga.com |
2025-02-13 17:10:11 |
Czytaj oryginał (ang.) |
| 10x Genomics, Inc. (TXG) Q4 2024 Earnings Call Transcript |
10x Genomics, Inc. (NASDAQ:TXG ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Cassie Corneau - Senior Director, IR and Strategic Finance Serge Saxonov - CEO and Co-Founder Adam Taich - CFO Conference Call Participants Dan Brennan - TD Cowen Patrick Donnelly - Citi Dan Arias - Stifel Puneet Souda - Leerink Partners Doug Schenkel - Wolfe Research Tycho Peterson - Jefferies Tejas Savant - Morgan Stanley Dan Leonard - UBS Subbu Nambi - Guggenheim Securities Kyle Mikson - Canaccord Genuity Luke Sergott - Barclays Matt Larew - William Blair Matt Sykes - Goldman Sachs Michael Ryskin - Bank of America Operator Thank you for standing by. My name is [Prilla] and I will be your conference operator today. |
seekingalpha.com |
2025-02-12 22:53:01 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings |
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-02-12 21:30:20 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates |
10x Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago. |
zacks.com |
2025-02-12 20:46:08 |
Czytaj oryginał (ang.) |
| 10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025 |
PLEASANTON, Calif. , Feb. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided outlook for 2025. |
prnewswire.com |
2025-02-12 18:05:00 |
Czytaj oryginał (ang.) |
| Seeking Clues to 10x Genomics (TXG) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics |
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024. |
zacks.com |
2025-02-11 12:20:21 |
Czytaj oryginał (ang.) |
| Cathie Wood dumped Palantir to buy these biotech stocks |
Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure. |
finbold.com |
2025-02-06 10:42:34 |
Czytaj oryginał (ang.) |
| Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology |
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance researchers' understanding of cellular behavior and gene function REDWOOD CITY, Calif. , Feb. 6, 2025 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in biology. |
prnewswire.com |
2025-02-06 10:30:00 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-05 13:05:23 |
Czytaj oryginał (ang.) |
| Torex Gold Provides Q4 2024 Update on Media Luna Project |
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides a Q4 2024 update on the development of its Media Luna Project ("Media Luna"). Unless otherwise stated, progress and milestones referenced in this press release are as of December 31, 2024. |
newsfilecorp.com |
2025-02-04 20:00:00 |
Czytaj oryginał (ang.) |
| Cathie Wood's Top Biotech Plays for February |
Don't look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns. |
247wallst.com |
2025-02-02 21:40:23 |
Czytaj oryginał (ang.) |
| Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE |
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Spatial Omics Market by Technology, by Product, by Workflow, by Sample Type, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering. The global spatial OMICS market accounted for USD 0.372 billion in 2023 and is expected to reach USD 1.09 billion by 2034 with a CAGR of 10.27% during the forecast period 2024-2034 |
globenewswire.com |
2025-01-31 08:34:00 |
Czytaj oryginał (ang.) |
| 10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 |
PLEASANTON, Calif. , Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025. |
prnewswire.com |
2025-01-28 18:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold Provides 2025 Operational Guidance and Updated Five-Year Production Outlook |
On track to return to positive free cash flow mid-year as Media Luna ramps up (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides 2025 operational guidance as well as an updated five-year production outlook for the Morelos Complex. Full-year guidance assumes a four-week shutdown of the processing plant during the first quarter to carry out upgrades and tie-ins required to complete the Media Luna Project. |
newsfilecorp.com |
2025-01-14 20:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Delivers on Full-Year Production Guidance |
2024 marks the sixth consecutive year production guidance has been achieved Toronto, Ontario--(Newsfile Corp. - January 8, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports fourth quarter gold production of 103,795 ounces ("oz") and full-year gold production of 452,523 oz, within the Company's revised guidance range of 450,000 to 470,000 oz (original guidance of 400,000 to 450,000 oz). Fourth quarter and full-year gold sold were 108,647 oz and 455,932 oz, respectively. |
newsfilecorp.com |
2025-01-08 20:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
PLEASANTON, Calif. , Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. |
prnewswire.com |
2025-01-02 18:05:00 |
Czytaj oryginał (ang.) |
| Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought |
Even the perpetually moving Cathie Wood takes a step back over the holidays. The co-founder, CEO, and investment manager for Ark Invest has been slowing the pace of her portfolio moves lately. |
fool.com |
2024-12-24 09:30:00 |
Czytaj oryginał (ang.) |
| U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products |
PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. |
prnewswire.com |
2024-12-23 18:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold to Restart Operations and Project Activities at the Morelos Complex |
Toronto, Ontario--(Newsfile Corp. - December 17, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports that the Director General of Mines under the Federal Ministry of Economy has lifted the temporary suspension notice and allowed for all activities within the Morelos Complex to resume. Jody Kuzenko, President & CEO of Torex, stated: "Following notification that the temporary suspension has been lifted by the Director General of Mines, all production and development activities at the Morelos Complex will resume, including open pit and underground mining, processing operations, and all activities associated with the Media Luna Project. |
newsfilecorp.com |
2024-12-17 18:57:00 |
Czytaj oryginał (ang.) |
| Torex Gold Receives Notice of Temporary Suspension from the Ministry of Economy |
Toronto, Ontario--(Newsfile Corp. - December 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports that the Company has received a notification from the Director General of Mines under the Federal Ministry of Economy that all activities within the Morelos Property are to be temporarily suspended to support their inspection associated with the fatal incident at the El Limón Guajes underground mine ("ELG Underground") on December 5th. As a result, all operational and project activities within the Morelos Complex have been temporarily halted pending permission from officials to resume activities. |
newsfilecorp.com |
2024-12-09 22:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Provides an Update on the Fatalities at ELG Underground |
Toronto, Ontario--(Newsfile Corp. - December 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides an update on the carbon monoxide exposure at the El Limón Guajes underground mine ("ELG Underground") that claimed the lives of two employees and one contractor and injured a second contractor. The relevant authorities have all been notified and the Company is fully cooperating with regulators. |
newsfilecorp.com |
2024-12-09 08:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Three Fatalities at the ELG Underground Mine |
Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) regretfully announces that during the day shift on December 5th, a fatal carbon monoxide gas exposure occurred, which claimed the lives of two employees and one contractor at the El Limón Guajes underground mine ("ELG Underground"). A fourth contract employee was also in the area and is currently in hospital and expected to recover. |
newsfilecorp.com |
2024-12-05 20:30:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program |
Results continue to indicate impressive grades and ongoing potential to expand resources and replace mined reserves (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces further assay results from the Company's 2024 drilling program at ELG Underground. The results to date support the Company's target of extending the mine life of ELG Underground by identifying new zones of higher-grade mineralization, expanding resources, and replacing and growing reserves. |
newsfilecorp.com |
2024-12-02 20:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Receives Approval for Normal Course Issuer Bid |
Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that it has received approval from the Toronto Stock Exchange (the "TSX") of its notice of intention to make a normal course issuer bid (the "NCIB"). Under the NCIB, Torex is authorized to purchase up to 7,116,777 of its common shares ("Common Shares"), representing approximately 10% of the public float as of November 13, 2024, during the period commencing on November 21, 2024 and ending on November 20, 2025. |
newsfilecorp.com |
2024-11-19 08:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program |
Results indicate strong potential to upgrade Inferred Resources to Indicated Resources and expand resources to the north of the deposit (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces assay results from the Company's ongoing drilling program at EPO. The results to date support Torex's goal of expanding resources to the north of the deposit and upgrading Inferred Resources to Indicated Resources. |
newsfilecorp.com |
2024-11-13 20:00:00 |
Czytaj oryginał (ang.) |
| 10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference |
PLEASANTON, Calif. , Nov. 7, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research 2024 Healthcare Conference on Tuesday, November 19, at 1:00 p.m. |
prnewswire.com |
2024-11-07 18:05:00 |
Czytaj oryginał (ang.) |
| Torex Gold Reports Q3 2024 Results |
Solid financial performance and robust cash generation driven by an all-in sustaining costs margin of 52% (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports the Company's financial and operational results for the three and nine months ended September 30, 2024. Torex will host a conference call tomorrow morning at 9:00 AM (ET) to discuss the results. |
newsfilecorp.com |
2024-11-06 20:00:00 |
Czytaj oryginał (ang.) |
| TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative |
Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors PARIS and PLEASANTON, Calif. , Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium HD as part of its pioneering work to understand the unique biology of exceptional cancer survivors, whose survival mechanisms could hold the key to new therapeutic approaches. |
prnewswire.com |
2024-10-31 10:00:00 |
Czytaj oryginał (ang.) |
| Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance |
Project 87% complete; plant tie-in schedule moves to February; first copper concentrate expected in Q1 (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - October 30, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides a Q3 2024 update on the development of its Media Luna Project ("Media Luna") and increases 2024 production guidance with a decision to undertake the tie-ins and upgrades to the processing plant in February 2025. Unless otherwise stated, progress and milestones referenced in this press release are as of September 30, 2024. |
newsfilecorp.com |
2024-10-30 20:00:00 |
Czytaj oryginał (ang.) |
| These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results |
10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday. |
benzinga.com |
2024-10-30 16:41:30 |
Czytaj oryginał (ang.) |
| 10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript |
10x Genomics, Inc. (NASDAQ:TXG ) Q3 2024 Earnings Conference Call October 29, 2024 4:30 PM ET Company Participants Cassie Corneau - Senior Director, Head of Investor Relations and Strategic Finance Serge Saxonov - Chief Executive Officer and Co-Founder Adam Taich - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Tycho Peterson - Jefferies Doug Schenkel - Wolfe Research Dan Arias - Stifel Nicolaus Dan Brennan - TD Cowen Mason Carrico - Stephens Puneet Souda - Leerink Partners Rachel Vatnsdal - J.P. Morgan Kyle Mikson - Canaccord Genuity Patrick Donnelly - Citi Michael Ryskin - Bank of America Subbu Nambi - Guggenheim Securities Matt Larew - William Blair Matt Sykes - Goldman Sachs Operator Thank you for standing by. |
seekingalpha.com |
2024-10-29 22:04:08 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates |
The headline numbers for 10x Genomics (TXG) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2024-10-29 22:01:12 |
Czytaj oryginał (ang.) |
| 10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates |
10x Genomics (TXG) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.51 per share a year ago. |
zacks.com |
2024-10-29 20:20:22 |
Czytaj oryginał (ang.) |
| 10x Genomics Reports Third Quarter 2024 Financial Results |
PLEASANTON, Calif. , Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2024. |
prnewswire.com |
2024-10-29 18:05:00 |
Czytaj oryginał (ang.) |
| Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell |
Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article. |
zacks.com |
2024-10-29 07:05:21 |
Czytaj oryginał (ang.) |